Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)

Historical Holders from Q4 2019 to Q4 2024

Symbol
APRE on Nasdaq
CUSIP
03836J102
Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
5.43M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-1
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HIRSCHMAN ORIN 9.9% $270K 539K Orin Hirschman Dec 31, 2024
Sio Capital Management, LLC 5.09% $138K 277K Sio Capital Management, LLC Dec 31, 2024

Institutional Holders of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 0 $0 -$2K 0
2024 Q3 899 $2K $0 $2.22 1
2024 Q2 899 $3K -$669 $3.34 1
2024 Q1 999 $6.67K +$6K $6.68 2
2023 Q4 100 $470 $0 $4.70 1
2023 Q3 100 $417 $0 $4.17 1
2023 Q2 100 $315 -$13 $3.15 1
2023 Q1 103 $457 -$520K $4.39 2
2022 Q4 1.59M $520K -$29.5K $0.33 23
2022 Q3 1.68M $1.09M -$365K $0.65 20
2022 Q2 1.47M $1.1M -$869K $0.75 25
2022 Q1 2.42M $4.5M -$2.77M $1.86 38
2021 Q4 3.61M $10.4M -$8.43M $2.87 34
2021 Q3 4.97M $25.4M -$7.62M $5.11 36
2021 Q2 6.54M $31.9M -$11.8M $4.88 48
2021 Q1 8.9M $45.3M -$6.92M $5.10 65
2020 Q4 9.45M $46.5M -$98.1M $4.92 60
2020 Q3 16.6M $399M +$3.16M $24.06 62
2020 Q2 16.3M $633M +$112M $38.78 62
2020 Q1 13.4M $466M +$17.9M $34.76 49
2019 Q4 12.9M $591M +$460M $45.89 39